The Development of Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale
NCT ID: NCT06603389
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
330 participants
OBSERVATIONAL
2022-11-01
2024-05-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical and Psychosocial Characteristics of Adolescent Patients With Non-Suicidal Self-Injury
NCT06885749
A Study on Improving Detection and Management of Suicide Risk Among Depressed Patients in Primary Care
NCT00386711
Investigation on Risk Factors for Suicide Among Chinese Patients With Mood Disorders
NCT07281729
Suicide Risk Scale and Distress Intervention for the Patients With Chronic Medical Illness or Physical Disabilities
NCT04441060
Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
NCT06207279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observation Group
Scales are used to get primary indicator and secondary indicators. The sample size should be set at 5 to 10 times the number of items, with a minimum total sample of 200. Additionally, an extra sample should be calculated to account for a potential 10-20% attrition rate, mitigating the impact of possible data loss. Given that the initial version scale consisted of 55 items, the minimum required sample size is 330.
Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale
sacles or questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale
sacles or questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Gender is not limited and aged is 12-30 years old;
3. The patient's clinical profile is complete and the medical history is detailed;
4. Informed consent from patients or guardians who signed a consent for.
Exclusion Criteria
12 Years
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shantou University Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tang Hao
Master of Nursing Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jingfang Chen, Bachelor
Role: STUDY_DIRECTOR
Shantou University Mental Health Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shantou University Mental Health Center
Shantou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202305
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.